BTC
Basic information
Region (hg38): 4:74744759-74794523
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BTC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 1 |
Variants in BTC
This is a list of pathogenic ClinVar variants found in the BTC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-74748091-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
4-74748100-T-C | not specified | Uncertain significance (May 27, 2022) | ||
4-74748104-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
4-74748115-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
4-74748136-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
4-74750589-C-A | not specified | Uncertain significance (Nov 06, 2023) | ||
4-74750592-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
4-74750603-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
4-74750628-T-G | not specified | Uncertain significance (May 09, 2022) | ||
4-74750648-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
4-74750673-A-G | not specified | Uncertain significance (May 18, 2023) | ||
4-74750684-C-T | not specified | Uncertain significance (Mar 31, 2022) | ||
4-74750689-A-C | not specified | Uncertain significance (Jun 30, 2023) | ||
4-74750691-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
4-74750703-T-A | not specified | Uncertain significance (Jul 12, 2023) | ||
4-74750713-A-C | not specified | Uncertain significance (May 27, 2022) | ||
4-74770091-G-A | Benign (Jun 18, 2018) | |||
4-74770147-A-T | not specified | Uncertain significance (Sep 21, 2023) | ||
4-74794280-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
4-74794310-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
4-74794310-G-C | not specified | Uncertain significance (Dec 05, 2022) | ||
4-74794312-G-A | not specified | Uncertain significance (Jul 30, 2023) | ||
4-74794318-C-G | not specified | Likely benign (Oct 18, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BTC | protein_coding | protein_coding | ENST00000395743 | 5 | 49928 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0623 | 0.876 | 125738 | 0 | 5 | 125743 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.126 | 104 | 100 | 1.04 | 0.00000553 | 1137 |
Missense in Polyphen | 21 | 23.537 | 0.89222 | 285 | ||
Synonymous | 0.122 | 35 | 35.9 | 0.974 | 0.00000187 | 354 |
Loss of Function | 1.57 | 3 | 7.71 | 0.389 | 3.26e-7 | 113 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000622 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000358 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Growth factor that binds to EGFR, ERBB4 and other EGF receptor family members. Potent mitogen for retinal pigment epithelial cells and vascular smooth muscle cells. {ECO:0000269|PubMed:8570211}.;
- Pathway
- ErbB signaling pathway - Homo sapiens (human);EGFR Inhibitor Pathway, Pharmacodynamics;EGF-Core;ErbB Signaling Pathway;SHC1 events in ERBB2 signaling;Signaling by PTK6;Disease;Signal Transduction;ERBB2 Activates PTK6 Signaling;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;Downregulation of ERBB2 signaling;GPCR signaling-G alpha s PKA and ERK;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;PIP3 activates AKT signaling;GRB2 events in ERBB2 signaling;Signaling by Non-Receptor Tyrosine Kinases;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI3K events in ERBB2 signaling;Signaling by ERBB2;ERBB2 Regulates Cell Motility;SHC1 events in ERBB4 signaling;PI3K/AKT Signaling in Cancer;PI3K events in ERBB4 signaling;GPCR signaling-G alpha i;Nuclear signaling by ERBB4;Signaling by ERBB4;Signaling by Receptor Tyrosine Kinases;Intracellular signaling by second messengers;Diseases of signal transduction;ErbB receptor signaling network
(Consensus)
Recessive Scores
- pRec
- 0.239
Intolerance Scores
- loftool
- 0.524
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.27
Haploinsufficiency Scores
- pHI
- 0.395
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.417
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Btc
- Phenotype
- growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); skeleton phenotype;
Gene ontology
- Biological process
- MAPK cascade;epidermal growth factor receptor signaling pathway;positive regulation of cell population proliferation;regulation of signaling receptor activity;peptidyl-tyrosine phosphorylation;positive regulation of urine volume;ERBB2 signaling pathway;negative regulation of apoptotic process;positive regulation of cell differentiation;positive regulation of mitotic nuclear division;phosphatidylinositol phosphorylation;positive regulation of fibroblast proliferation;positive regulation of cell division;positive regulation of protein kinase B signaling;regulation of cell motility
- Cellular component
- extracellular region;extracellular space;plasma membrane;integral component of membrane
- Molecular function
- protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;epidermal growth factor receptor binding;protein binding;growth factor activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity